Global Carbidopa (CAS 28860-95-9) Market Outlook 2016-2021
- GEN713906
- 108 Pages
- September 2016
- Pharmaceuticals
Carbidopa, an inhibitor of aromatic amino acid decarboxylation, is a white, crystalline compound, slightly soluble in water, with a molecular weight of 244.3. It is designated chemically as (-)-L-?-hydrazino-?-methyl-?-(3,4-dihydroxybenzene) propanoic acid monohydrate. Its empirical formula is C10H14N2O4•H2O. Used in tandem with L-DOPA (also known as levodopa, a dopamine precursor converted in the body to dopamine), it increases the plasma half-life of levodopa from 50 minutes to 1½ hours. CarbiDOPA cannot cross the blood–brain barrier, so it inhibits only peripheral DDC. It thus prevents the conversion of L-DOPA to dopamine peripherally. This reduces the side effects caused by dopamine on the periphery, as well as increasing the concentration of L-DOPA and dopamine in the brain.
This report provides detailed analysis of worldwide markets for Carbidopa (CAS 28860-95-9) from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Carbidopa (CAS 28860-95-9) market and further lays out an analysis of the factors influencing the supply/demand for Carbidopa (CAS 28860-95-9), and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.
GCC’s report, Global Carbidopa (CAS 28860-95-9) Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Carbidopa (CAS 28860-95-9) market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Carbidopa (CAS 28860-95-9) market are Novartis, Merck Sharp & Dohme, AbbVie, Allergan, Teva, Impax, WOCKHARDT, Wild Wind Pharmaceutical, Chiral Chem, Mylan N.V., Valeant, among others.
The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Carbidopa (CAS 28860-95-9) industry has been provided.
Part 1. Scope of Report
1.1 Methodology
1.2 Geographic Scope
1.3 Years Considered
Part 2. Introduction
2.1 Definition
2.2 Current Scenario
2.2 Future Scenario
Part.3 Value Chain Analysis
3.1 Upstream
3.2 Downstream
Part 4. Manufacture
4.1 Manufacturing Process
4.2 Issues and Trends
4.3 Manufacturing Costs
Part 5. Worldwide Key Vendors
5.1 Company A
5.1.1 Business Overview
5.1.2 Products Offered
5.1.3 Business Performance
5.2 Company B
5.3 Company C
5.4 Company D
5.5 Company E
5.6 Company F
5.7 Company G
5.8 Company H
5.9 Company I
5.10 Company J
Part 6. Market Overview
6.1 Global Production Volume 2011-2016
6.2 Production Volume by Region 2011-2016
6.2.1 North America
6.2.2 EMEA
6.2.3 Asia-Pacific
6.2.4 ROW
6.3 Global Production Value 2011-2016
6.4 Production Value by Region
6.4.1 North America
6.4.2 EMEA
6.4.3 Asia-Pacific
6.4.4 ROW
Part 7. Consumption Pattern
7.1 Regional Consumption
7.1.1 North America
7.1.2 EMEA
7.1.3 Asia-Pacific
7.1.4 ROW
7.2 Global Consumption by Application
Part 8. Market Forecast
8.1 Market Size by Volume
8.1.1 North America
8.1.2 EMEA
8.1.3 Asia-Pacific
8.1.4 ROW
8.2 Market Size by Value
8.2.1 North America
8.2.2 EMEA
8.2.3 Asia-Pacific
8.2.4 ROW
8.3 Regional Consumption Forecast
8.3.1 North America
8.3.2 EMEA
8.3.3 Asia-Pacific
8.3.4 ROW
8.4 Consumption Forecast by Application
Part 9. Market Dynamics
9.1 Market Drivers
9.2 Market Constraints
9.3 Market Strategies
Part 10 Key Events
10.1 Mergers & Acquisitions
10.2 New Product Launches
10.3 Expansions
10.4 Other Developments
List Of Tables
Figure Global Carbidopa (CAS 28860-95-9) Production Volume (Unit) 2011-2016
Figure Global Carbidopa (CAS 28860-95-9) Production Value (M USD) 2011-2016
Figure Top 10 Carbidopa (CAS 28860-95-9) Vendors Production Volume Share 2015
Figure Top 10 Carbidopa (CAS 28860-95-9) Vendors Production Value Share 2015
Figure Regional Carbidopa (CAS 28860-95-9) Production (Unit) 2015
Figure Regional Carbidopa (CAS 28860-95-9) Production Value (M USD) 2015
Table Raw Material Materials Suppliers
Figure Global Carbidopa (CAS 28860-95-9) Consumption Pattern 2015
Figure Manufacturing Cost Structure
Figure Company A Carbidopa (CAS 28860-95-9) Products
Table Company A Financial Performance 2011-2016
Figure Company A Market Share 2011-2016
Figure Company B Carbidopa (CAS 28860-95-9) Products
Table Company B Financial Performance 2011-2016
Figure Company B Market Share 2011-2016
Figure Company C Carbidopa (CAS 28860-95-9) Products
Table Company C Financial Performance 2011-2016
Figure Company C Market Share 2011-2016
Figure Company D Carbidopa (CAS 28860-95-9) Products
Table Company D Financial Performance 2011-2016
Figure Company D Market Share 2011-2016
Figure Company E Carbidopa (CAS 28860-95-9) Products
Table Company E Financial Performance 2011-2016
Figure Company E Market Share 2011-2016
Figure Company F Carbidopa (CAS 28860-95-9) Products
Table Company F Financial Performance 2011-2016
Figure Company F Market Share 2011-2016
Figure Company G Carbidopa (CAS 28860-95-9) Products
Table Company G Financial Performance 2011-2016
Figure Company G Market Share 2011-2016
Figure Company H Carbidopa (CAS 28860-95-9) Products
Table Company H Financial Performance 2011-2016
Figure Company H Market Share 2011-2016
Figure Company I Carbidopa (CAS 28860-95-9) Products
Table Company I Financial Performance 2011-2016
Figure Company I Market Share 2011-2016
Figure Company J Carbidopa (CAS 28860-95-9) Products
Table Company J Financial Performance 2011-2016
Figure Company J Market Share 2011-2016
Table Global Key Carbidopa (CAS 28860-95-9) Vendors Production (Unit) 2011-2016
Table Global Key Carbidopa (CAS 28860-95-9) Vendors Production Share 2011-2016
Figure Global Carbidopa (CAS 28860-95-9) Capacity & Production (Unit), Capacity Utilization 2011-2016
Figure Global Top 10 Carbidopa (CAS 28860-95-9) Vendors Production (Unit) 2011-2016
Table Global Top 10 Carbidopa (CAS 28860-95-9) Vendors Production (Unit) 2011
Table Global Top 10 Carbidopa (CAS 28860-95-9) Vendors Production (Unit) 2012
Table Global Top 10 Carbidopa (CAS 28860-95-9) Vendors Production (Unit) 2013
Table Global Top 10 Carbidopa (CAS 28860-95-9) Vendors Production (Unit) 2014
Table Global Top 10 Carbidopa (CAS 28860-95-9) Vendors Production (Unit) 2015
Table Global Top 10 Carbidopa (CAS 28860-95-9) Vendors Production (Unit) 2016
Figure Carbidopa (CAS 28860-95-9) Production Volume (Unit) 2011-2016
Table Global Production Volume (Unit) 2011-2016
Table Global Production Volume Share 2011-2016
Figure North America Carbidopa (CAS 28860-95-9) Capacity & Production (Unit)
Figure North America Production Share Trend
Figure EMEA Carbidopa (CAS 28860-95-9) Capacity & Production (Unit)
Figure EMEA Production Share Trend
Figure Asia-Pacific Carbidopa (CAS 28860-95-9) Capacity & Production (Unit)
Figure Asia-Pacific Production Share Trend
Figure ROW Carbidopa (CAS 28860-95-9) Capacity & Production (Unit)
Figure ROW Production Share Trend Change
Figure Global Carbidopa (CAS 28860-95-9) Production Value (M USD), Growth Rate
Table Global Key Carbidopa (CAS 28860-95-9) Vendors Production Value (M USD) 2011-2016
Table Global Key Carbidopa (CAS 28860-95-9) Vendors Production Value Share 2011-2016
Figure Global Top 10 Carbidopa (CAS 28860-95-9) Vendors Production Value (M USD) 2011-2016
Table Global Top 10 Carbidopa (CAS 28860-95-9) Vendors Production Value (M USD) 2011
Table Global Top 10 Carbidopa (CAS 28860-95-9) Vendors Production Value (M USD) 2012
Table Global Top 10 Carbidopa (CAS 28860-95-9) Vendors Production Value (M USD) 2013
Table Global Top 10 Carbidopa (CAS 28860-95-9) Vendors Production Value (M USD) 2014
Table Global Top 10 Carbidopa (CAS 28860-95-9) Vendors Production Value (M USD) 2015
Table Global Top 10 Carbidopa (CAS 28860-95-9) Vendors Production Value (M USD) 2016
Figure Carbidopa (CAS 28860-95-9) Prices (USD/Ton) 2016
Figure Carbidopa (CAS 28860-95-9) Gross Margin 2016
Figure Carbidopa (CAS 28860-95-9) Production Value (M USD) By Region 2011-2016
Table Global Carbidopa (CAS 28860-95-9) Production Value (M USD) 2011-2016
Table Global Carbidopa (CAS 28860-95-9) Production Value Share 2011-2016
Figure North America Production Value (M USD), Growth Rate
Figure North America Carbidopa (CAS 28860-95-9) Production Value Share Trend
Figure EMEA Production Value (M USD), Growth Rate
Figure EMEA Carbidopa (CAS 28860-95-9) Production Value Share Trend
Figure Asia-Pacific Production Value (M USD), Growth Rate
Figure Asia-Pacific Carbidopa (CAS 28860-95-9) Production Value Share Trend
Figure ROW Production Value (M USD), Growth Rate
Figure ROW Carbidopa (CAS 28860-95-9) Production Value Share Trend
Figure Global Carbidopa (CAS 28860-95-9) Consumption Volume (Unit) 2015
Table Regional Carbidopa (CAS 28860-95-9) Consumption Volume (Unit) 2011-2016
Table Regional Carbidopa (CAS 28860-95-9) Consumption Volume Share 2011-2016
Figure Carbidopa (CAS 28860-95-9) Consumption in North America 2011-2016
Figure Carbidopa (CAS 28860-95-9) Consumption in EMEA 2011-2016
Figure Carbidopa (CAS 28860-95-9) Consumption in Asia-Pacific 2011-2016
Figure Carbidopa (CAS 28860-95-9) Consumption in ROW 2011-2016
Figure Global Carbidopa (CAS 28860-95-9) Consumption Volume (Unit) 2016
Table Global Carbidopa (CAS 28860-95-9) Consumption Volume (Unit) 2011-2016
Table Global Carbidopa (CAS 28860-95-9) Consumption Volume Share 2011-2016
Figure Global Carbidopa (CAS 28860-95-9) Production (Unit) Forecast 2016-2021
Table Global Carbidopa (CAS 28860-95-9) Production (Unit) 2016-2021
Table Global Carbidopa (CAS 28860-95-9) Production Share 2016-2021
Figure North Carbidopa (CAS 28860-95-9) Production (Unit) Forecast 2016-2021
Figure EMEA Carbidopa (CAS 28860-95-9) Production (Unit) Forecast 2016-2021
Figure Asia-Pacific Carbidopa (CAS 28860-95-9) Production (Unit) Forecast 2016-2021
Figure ROW Carbidopa (CAS 28860-95-9) Production (Unit) Forecast 2016-2021
Figure Global Carbidopa (CAS 28860-95-9) Revenue (M USD) Forecast 2016-2021
Table Global Carbidopa (CAS 28860-95-9) Revenue (M USD) 2016-2021
Table Global Carbidopa (CAS 28860-95-9) Revenue Share 2016-2021
Figure North America Carbidopa (CAS 28860-95-9) Revenue (M USD) Forecast 2016-2021
Figure EMEA Carbidopa (CAS 28860-95-9) Revenue (M USD) Forecast 2016-2021
Figure Asia-Pacific Carbidopa (CAS 28860-95-9) Revenue (M USD) Forecast 2016-2021
Figure ROW Carbidopa (CAS 28860-95-9) Revenue (M USD) Forecast 2016-2021
Figure Global Carbidopa (CAS 28860-95-9) Consumption Volume (Unit) 2016-2021
Table Global Carbidopa (CAS 28860-95-9) Consumption Volume (Unit) 2016-2021
Table Global Carbidopa (CAS 28860-95-9) Consumption Volume Share 2016-2021
Figure North America Carbidopa (CAS 28860-95-9) Consumption (Unit) Forecast
Figure EMEA Carbidopa (CAS 28860-95-9) Consumption (Unit) Forecast
Figure Asia-Pacific Carbidopa (CAS 28860-95-9) Consumption (Unit) Forecast
Figure ROW Carbidopa (CAS 28860-95-9) Consumption (Unit) Forecast
Figure Global Carbidopa (CAS 28860-95-9) Consumption Volume (Unit) 2021
Table Global Carbidopa (CAS 28860-95-9) Consumption Volume (Unit) 2016-2021
Table Global Carbidopa (CAS 28860-95-9) Consumption Volume Share 2016-2021
Table Key Strategies for Carbidopa (CAS 28860-95-9) Multinational Corporations
Table Key Strategies for Carbidopa (CAS 28860-95-9) Emerging-Market Players
List Of Figures
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
